Literature DB >> 8401092

Outcome in colorectal adenocarcinoma: two seven-year studies of a population.

N L Gordon1, A A Dawson, B Bennett, G Innes, O Eremin, P F Jones.   

Abstract

OBJECTIVE: To record every patient with proved colorectal adenocarcinoma presenting from a defined population over two years in 1968-9 and during 1980-2, and to compare treatment and outcome over seven years.
DESIGN: Retrospective in 1968-9 and prospective in 1980-2.
SETTING: Aberdeen general hospitals.
SUBJECTS: Every patient presenting to the four general surgical units with histological proof of colorectal adenocarcinoma. MAIN
FINDINGS: On average, one new patient presented each week per 100,000 population. The proportion of patients aged 65 and over rose from 67% to 71%. An operation was performed on 385 patients in 1968-9 and on 399 during 1980-2. At laparotomy the proportion of patients who seemed to be curable and had a radical operation rose slightly, from 56% to 61%, and operative mortality fell from 9% to 5%. In all there were 421 survivors of curative surgery, and seven years later three quarters were either alive (51%) or had died without recurrence (25%). In both studies some 40% of patients were considered incurable when they presented, but the number who had a palliative resection rose from 59% to 85%.
CONCLUSIONS: The contribution of radical surgery to the treatment of colorectal adenocarcinoma is substantial, with three quarters of patients so treated showing no evidence of recurrence after seven years. Operative mortality in an elderly population is now low, and improvement in late outcome is more likely to come from developments in adjuvant therapy than in operative technique. A continuing problem is that 40% of patients are not curable when they present, although palliative resection can now be offered to over 80%.

Entities:  

Mesh:

Year:  1993        PMID: 8401092      PMCID: PMC1678695          DOI: 10.1136/bmj.307.6906.707

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  16 in total

1.  Growth rate of hepatic metastases in colorectal carcinoma.

Authors:  I G Finlay; D Meek; F Brunton; C S McArdle
Journal:  Br J Surg       Date:  1988-07       Impact factor: 6.939

2.  Occult hepatic metastases in colorectal carcinoma.

Authors:  I G Finlay; C S McArdle
Journal:  Br J Surg       Date:  1986-09       Impact factor: 6.939

3.  Vascularization of small liver metastases.

Authors:  S G Archer; B N Gray
Journal:  Br J Surg       Date:  1989-06       Impact factor: 6.939

4.  Trial of low-dose aspirin plus dipyridamole versus anticoagulants for prevention of aortocoronary vein graft occlusion.

Authors:  M Pfisterer; F Burkart; G Jockers; B Meyer; S Regenass; D Burckhardt; H E Schmitt; J Müller-Brand; K Skarvan; P Stulz
Journal:  Lancet       Date:  1989-07-01       Impact factor: 79.321

5.  Outcome in colorectal carcinoma: seven-year study of a population.

Authors:  D N Clarke; P F Jones; C D Needham
Journal:  Br Med J       Date:  1980-02-16

6.  Trends in right and left-sided colon cancer.

Authors:  R W Beart; L J Melton; M Maruta; M B Dockerty; H B Frydenberg; W M O'Fallon
Journal:  Dis Colon Rectum       Date:  1983-06       Impact factor: 4.585

7.  Operative mortality rate and surgery for colorectal cancer.

Authors:  S C Brown; S Walsh; P A Sykes
Journal:  Br J Surg       Date:  1988-07       Impact factor: 6.939

8.  Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.

Authors:  C G Moertel; T R Fleming; J S Macdonald; D G Haller; J A Laurie; P J Goodman; J S Ungerleider; W A Emerson; D C Tormey; J H Glick
Journal:  N Engl J Med       Date:  1990-02-08       Impact factor: 91.245

9.  Colorectal cancer in a small rural hospital.

Authors:  J Callaghan
Journal:  Am J Surg       Date:  1990-03       Impact factor: 2.565

10.  A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer.

Authors:  I Taylor; D Machin; M Mullee; G Trotter; T Cooke; C West
Journal:  Br J Surg       Date:  1985-05       Impact factor: 6.939

View more
  7 in total

Review 1.  Systems approaches to surgical quality and safety: from concept to measurement.

Authors:  Charles Vincent; Krishna Moorthy; Sudip K Sarker; Avril Chang; Ara W Darzi
Journal:  Ann Surg       Date:  2004-04       Impact factor: 12.969

2.  Follow up of patients with colorectal cancer: no simple solutions.

Authors:  J M Gollock
Journal:  Br J Gen Pract       Date:  1995-06       Impact factor: 5.386

Review 3.  Gastroenterology--II: Small and large bowel, pancreas and biliary system.

Authors:  M C Bateson
Journal:  Postgrad Med J       Date:  1994-09       Impact factor: 2.401

4.  Survival after rectal cancer: differences between hospital catchment areas. A nationwide study in Sweden.

Authors:  P Blomqvist; A Ekbom; O Nyrén; U B Krusemo; R Bergström; H O Adami
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

5.  Survival after colon cancer 1973-1990 in Sweden. Convergence between catchment areas.

Authors:  P Blomqvist; A Ekbom; O Nyrén; U Krusemo; R Bergström; H O Adami
Journal:  Ann Surg       Date:  1997-02       Impact factor: 12.969

Review 6.  Morbidity and Mortality Rounds in Liver Transplantation.

Authors:  Peri Kocabayoglu; Martin Husen; Oliver Witzke; Andreas Kribben; Fuat H Saner; Ali Canbay; Guido Gerken; Andreas Paul
Journal:  Visc Med       Date:  2016-07-29

Review 7.  Adjuvant chemotherapy for colorectal cancer.

Authors:  Z Rayter; R J Leicester; J L Mansi
Journal:  Ann R Coll Surg Engl       Date:  1995-03       Impact factor: 1.891

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.